Ginkgo Bioworks Holdings, Inc. (DNA) — Stock Price, Chart & Analysis
Ginkgo Bioworks Holdings, Inc. (DNA) is a Healthcare stock currently trading at $9.37, up 17.42% on the day. It carries a market capitalization of $630.98M. Over the past 52 weeks, DNA has traded between $5.37 and $17.58. Ginkgo Bioworks Holdings, Inc. does not currently pay a regular dividend. View the live DNA chart, technical opinion, analyst ratings, fundamentals and latest news below.
Ginkgo Bioworks Holdings, Inc. (DNA) key data
| Price | $9.37 |
| Change (today) | +17.42% |
| Previous close | $7.98 |
| Market cap | $630.98M |
| EPS (TTM) | $-6.26 |
| 52-week high | $17.58 |
| 52-week low | $5.37 |
| Beta | 1.77 |
| Avg. volume | 1.15M |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently asked questions about Ginkgo Bioworks Holdings, Inc. (DNA)
How much does one share of Ginkgo Bioworks Holdings, Inc. cost?
As of the latest update, one share of Ginkgo Bioworks Holdings, Inc. (DNA) trades at $9.37 (+17.42% today).
What is Ginkgo Bioworks Holdings, Inc.'s market cap?
Ginkgo Bioworks Holdings, Inc. has a market capitalization of approximately $630.98M.
What is Ginkgo Bioworks Holdings, Inc.'s earnings per share (EPS)?
Ginkgo Bioworks Holdings, Inc.'s trailing twelve-month EPS is $-6.26.
Does Ginkgo Bioworks Holdings, Inc. pay a dividend?
Ginkgo Bioworks Holdings, Inc. does not currently pay a regular dividend.
What is Ginkgo Bioworks Holdings, Inc.'s 52-week trading range?
Over the past year, DNA has traded between $5.37 and $17.58.
What is the analyst price target for Ginkgo Bioworks Holdings, Inc.?
The mean analyst price target for Ginkgo Bioworks Holdings, Inc. is $7.00. This is informational only and not investment advice.
Latest Ginkgo Bioworks Holdings, Inc. (DNA) news
- Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key FactsNews · Sep 16, 2026
- Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab DataNews · Sep 16, 2026
- Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA MedicinesNews · Sep 10, 2026
- The Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Have Been Trimming Their Sales ForecastsNews · May 13, 2026
- Ginkgo Bioworks Q2 Earnings Call HighlightsNews · Aug 8, 2026
- Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug DiscoveryNews · May 26, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live DNA dashboard…